Gene fusion mechanisms offer new clues to origin of pediatric brain tumors

Mar 09, 2011

A detailed analysis of gene fusions present at high frequency in the most common pediatric brain tumors has been performed for the first time in a study published online today in Genome Research, shedding new light on how these genomic rearrangements form in the early stages of cancer.

Genomic rearrangements, genetic changes that alter the structure of chromosomes, have a positive role in evolution by creating and new genes; however, rearrangements can also predispose to or potentially initiate diseases such as cancer. Gene fusions as a result of genomic rearrangement have been observed in several types of cancer, and recently two gene fusions involving the RAF gene family were identified in the majority of pilocytic astrocytomas, the most common type of pediatric brain tumor.

RAF gene fusions have been shown to activate the MAP kinase pathway, a cell-signaling pathway linked to tumor formation. However, the mechanisms by which the RAF gene fusions form remained largely unknown. A team of researchers from the United Kingdom and the United States has now analyzed in detail the surrounding the points of the genome that are broken and abnormally fused, uncovering clues to the origin of childhood .

The group sequenced and analyzed DNA around the breakpoints of the fused genes in 42 pediatric low-grade astrocytomas, finding a particular pattern of DNA sequence occurring more commonly than expected. "We were particularly interested to find significant enrichment of a pattern in the DNA sequence called microhomology," said Dr. Denise Sheer of Queen Mary University of London, a senior author of the report.

Sheer described microhomology as the occurrence of several nucleotides, or letters, of DNA at the gene fusion breakpoints that are identical in the two genes involved in the fusion. She explained that this is consistent with a recently proposed mechanism of genomic rearrangement, where microhomology mediates the erroneous joining of DNA fragments during the repair of DNA breaks.

The authors further noted that the characteristics of RAF gene fusions in low-grade astrocytomas studied here could be relevant in other cancers. "The mechanism of gene malfunction that we have uncovered might apply to a large range of cancers in which other types of gene fusion occur," said Dr. David Ellison of St. Jude Children's Research Hospital, also a senior author of the report. "This is an important principle that could help us to understand how cancers start."

Explore further: Down's chromosome cause genome-wide disruption

More information: Lawson ARJ, Hindley GFL, Forshew T, Tatevossian RG, Jamie GA, Kelly GP, Neale GA, Ma J, Jones TA, Ellison DW, Sheer D. RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology. Genome Res doi: 10.1101/gr.115782.11

add to favorites email to friend print save as pdf

Related Stories

Researchers discover new genes that fuse in cancer

Jan 11, 2009

Using new technologies that make it easier to sequence the human genome, researchers at the University of Michigan Comprehensive Cancer Center have identified a series of genes that become fused when their chromosomes trade ...

Recommended for you

Down's chromosome cause genome-wide disruption

12 hours ago

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

Research uncovers DNA looping damage tied to HPV cancer

19 hours ago

It's long been known that certain strains of human papillomavirus (HPV) cause cancer. Now, researchers at The Ohio State University have determined a new way that HPV might spark cancer development – by ...

New therapy against rare gene defects

Apr 15, 2014

On 15th April is the 1st International Pompe Disease Day, a campaign to raise awareness of this rare but severe gene defect. Pompe Disease is only one of more than 40 metabolic disorders that mainly affect children under ...

User comments : 0

More news stories

Firm targets 3D printing synthetic tissues, organs

(Medical Xpress)—A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company ...

Survival hope for melanoma patients thanks to new vaccine

(Medical Xpress)—University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability ...

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

Biologists help solve fungi mysteries

(Phys.org) —A new genetic analysis revealing the previously unknown biodiversity and distribution of thousands of fungi in North America might also reveal a previously underappreciated contributor to climate ...

Robotics goes micro-scale

(Phys.org) —The development of light-driven 'micro-robots' that can autonomously investigate and manipulate the nano-scale environment in a microscope comes a step closer, thanks to new research from the ...